ISRCTN ISRCTN22532458
DOI https://doi.org/10.1186/ISRCTN22532458
Secondary identifying numbers 237124; ACTRN12606000234516
Submission date
02/02/2005
Registration date
03/05/2005
Last edited
18/12/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Jane Halliday
Scientific

Public Health Genetics Unit
10th floor Murdoch Childrens Research Institute
Flemington Road
Parkville
3052
Australia

Phone +61 (0)3 8341 6260
Email jane.halliday@mcri.edu.au

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeScreening
Scientific titleA randomised controlled trial of a decision aid for prenatal screening and diagnosis
Study acronymADEPT
Study objectivesCompared with pregnant women receiving a pamphlet, pregnant women who receive a decision aid on prenatal testing for foetal abnormality will have:
1. A higher rate of informed choice
2. Less decisional conflict
Ethics approval(s)Ethics Committee of Royal Australian College of General Practitioners gave approval on the 20th December 2004 (ref: NREEC 03-16)
Health condition(s) or problem(s) studiedPrenatal testing of foetal abnormalities
InterventionDecision aid versus pamphlet:
1. The decision aid for prenatal testing of foetal abnormalities has been developed using the three steps of the Ottawa Decision Support framework:
1.1. Identifying needs
1.2. Providing decision support
1.3. Evaluating decision support
2. The pamphlet has been developed by Genetic Health Services Victoria (GHSV). The pamphlet contains information on maternal age related risk, screening and diagnostic tests, a table summarising the tests available and what conditions they detect.

Data will be collected from women using questionnaires at 14 weeks and 24 weeks gestation.
Intervention typeOther
Primary outcome measure1. Informed choice, measured by the percentage of women in each arm of the trial identified as making an informed choice using the multi-dimensional measure of informed choice (MMIC) scale
2. Decisional conflict, measured by the difference in mean scores of the Decisional Conflict Scale between women in each arm
Secondary outcome measures1. Anxiety
2. Depression
3. Attachment to the pregnancy/foetus
4. Acceptability of the decision aid to both woman and GP
Overall study start date01/08/2004
Completion date30/04/2006

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participants500
Key inclusion criteriaPregnant women attending a participating general practice (GP) were eligible to participate provided they were:
1. Aged 18 years or older
2. Equal to or less than 12 weeks gestation
Key exclusion criteria1. Non-English speaking
2. Were unable to give written informed consent
3. Required genetic counselling due to a family history of an inherited condition or recurrent risk for foetal abnormality
4. Having already undertaken testing for foetal abnormality in this pregnancy
5. Experiencing vaginal bleeding
6. Currently having a known multiple pregnancy
Date of first enrolment01/08/2004
Date of final enrolment30/04/2006

Locations

Countries of recruitment

  • Australia

Study participating centre

Public Health Genetics Unit
Parkville
3052
Australia

Sponsor information

Murdoch Childrens Research Institute (MCRI) (Australia)
Research organisation

Royal Childrens Hospital
Flemington Road
Parkville
3052
Australia

Phone +61 (0)3 8341 6200
Email jane.halliday@mcri.edu.au
Website http://www.mcri.edu.au/
ROR logo "ROR" https://ror.org/048fyec77

Funders

Funder type

Research council

National Health and Medical Research Council (NHMRC) (Australia)
Government organisation / National government
Alternative name(s)
NHMRC
Location
Australia

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article Protocol 13/04/2006 Yes No
Results article Results 01/02/2008 Yes No

Editorial Notes

18/12/2017: internal review.